Discover · The Research Behind It
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis — Henssler et al., Lancet Psychiatry 2024
Last checked
- Free
- Worldwide
- Research paper
- Reading
- Online
Never stop or reduce a prescribed medicine on your own: some medicines cause withdrawal effects or a relapse if they are stopped or cut down too quickly. Use these resources to plan it with your prescriber.
- Published in
- The Lancet Psychiatry, 2024
- Evidence
- Moderate
- Cost
- Free.
What is this paper about?
Pooled 79 studies (21,002 people) in which an antidepressant or placebo was stopped. At least one discontinuation symptom followed stopping an antidepressant in 31% (95% CI 27–35%) versus 17% after placebo; severe symptoms in 2.8% versus 0.6%. Allowing for non-specific effects seen with placebo, the authors estimate about 15% (one in six to seven). Desvenlafaxine, venlafaxine, imipramine, escitalopram and paroxetine were linked to more frequent or severe symptoms.
Why is it in the directory?
Backs up the antidepressant tapering listings in chapter 06 with a large, recent estimate of how often discontinuation symptoms occur, and helps readers weigh it against higher survey-based figures such as Davies and Read's.
Is it free to read?
Systematic review and meta-analysis — 79 studies (44 randomised trials, 35 observational), 21,002 people. Moderate evidence. Lancet Psychiatry 2024;11(7):526–535. Free full text at the publisher — open access, CC BY 4.0.
About the paper
- Authors
- Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C.
- Published in
- Lancet Psychiatry 2024;11(7):526–535
- Kind of study
- Systematic review and meta-analysis — 79 studies (44 randomised trials, 35 observational), 21,002 people
- Strength of evidence
- Moderate — good studies, but fewer of them or with some limits
- Free to read
- CC BY 4.0 (open access at publisher)
Good to know
- Heterogeneity was substantial, studies defined and measured symptoms differently and many were small; it drew critical letters, including from Read and Davies, and an erratum in 2024.
Where it sits in the directory
Listed under “Coming Off Medication Safely — Tapering & Deprescribing” in chapter 17 of the directory, The Research Behind It, with 12 other listings in the same category.
Similar listings
Also in the directory, with why each one is here.
- A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? — Davies & Read, Addict Behav 2019
Also a free research paper available worldwide, also for clinicians, in the same category.
Reviewed 24 studies to test UK and US guideline statements that antidepressant withdrawal is 'self-limiting', typically resolving within one to two weeks.
- Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study — Groot & van Os, Ther Adv Psychopharmacol 2021
Also a free research paper available worldwide, also for clinicians, in the same category.
Surveyed people whose doctors had prescribed tapering strips (rolls of daily pouches, each the same as or slightly lower than the one before).
- Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial — Kendrick et al., JAMA Netw Open 2024
Also a free research paper available worldwide, also for clinicians, in the same category.
In 131 UK general practices, 330 adults on long-term antidepressants who were well, at low risk of relapse and wanted to try stopping had a GP review; practices…
- Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults — NICE 2022
Also a free research paper available worldwide, also for clinicians, in the same category.
NICE's guideline on withdrawing opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants.
- Surviving Antidepressants
A free community available worldwide, listed under “Medication Tapering & Deprescribing Directories” in Support Groups & Communities.
An international, peer-led information and withdrawal support forum, now archived in read-only mode.
- Deprescribing.org
A free tool or directory for people in Canada, also for clinicians, listed under “Medication Tapering & Deprescribing Directories” in Support Groups & Communities.
Evidence-based resources and tools for safely reducing or stopping medications, including deprescribing algorithms.
This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026; the link last loaded on 7 November 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.